Quantum Cyber N.V. Increase Decrease In Cash And Cash Equivalents
Quantum Cyber N.V. (QUCY) reported Increase Decrease In Cash And Cash Equivalents of -$4.32 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2025-09-26
- Quantum Cyber N.V. increase decrease in cash and cash equivalents for the quarter ending 2023-12-31 was -$2.25M.
- Quantum Cyber N.V. increase decrease in cash and cash equivalents for the quarter ending 2023-09-30 was -$1.59M.
- Quantum Cyber N.V. increase decrease in cash and cash equivalents for the quarter ending 2023-06-30 was $52.88K.
- Quantum Cyber N.V. increase decrease in cash and cash equivalents for the quarter ending 2023-03-31 was -$6.28M, a 129.57% decline year-over-year.
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 12 month | Increase Decrease In Cash And Cash Equivalents 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | -$4.32M 6-K · filed 2025-09-26 | ||||
| 2024-12-31 | -$835.25K 20-F · filed 2025-03-31 | ||||
| 2024-06-30 | -$6.09M 6-K · filed 2025-09-26 | ||||
| 2023-12-31 | -$2.25M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$3.84M derived: sum of 2 quarters · filed 2025-03-31 | -$3.79M derived: sum of 3 quarters · filed 2025-03-31 | -$10.07M 20-F · filed 2025-03-31 | |
| 2023-09-30 | -$1.59M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | -$1.54M derived: sum of 2 quarters · filed 2024-10-18 | -$7.82M 6-K · filed 2023-11-16 | -$12.69M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-06-30 | $52.88K derived: 6-K 6 month − 6-K 3 month · filed 2024-10-18 | -$6.23M 6-K · filed 2024-10-18 | -$11.10M derived: sum of 3 quarters · filed 2025-03-31 | -$15.10M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-03-31 | -$6.28M 6-K · filed 2023-05-16 | -$11.15M derived: sum of 2 quarters · filed 2025-03-31 | -$15.15M derived: sum of 3 quarters · filed 2025-03-31 | -$19.12M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2022-12-31 | -$4.86M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$8.86M derived: sum of 2 quarters · filed 2025-03-31 | -$12.83M derived: sum of 3 quarters · filed 2025-03-31 | $8.41M 20-F · filed 2025-03-31 | |
| 2022-09-30 | -$4.00M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | -$7.97M derived: sum of 2 quarters · filed 2023-11-16 | $13.28M 6-K · filed 2023-11-16 | ||
| 2022-06-30 | -$3.97M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $17.28M 6-K · filed 2023-08-15 | |||
| 2022-03-31 | $21.25M 6-K · filed 2023-05-16 | ||||
| 2021-12-31 | $8.60M 20-F · filed 2024-04-09 | ||||
| 2021-06-30 | $72.60K 6-K · filed 2022-09-07 | ||||
| 2020-12-31 | -$81.02K 20-F · filed 2023-04-07 | -$81.74K 20-F · filed 2022-05-03 | |||
| 2019-12-31 | $7.50K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |